Functional dissection identifies a conserved noncoding sequence-1 core that mediates IL13 and IL4 transcriptional enhancement
- PMID: 17166845
- DOI: 10.1074/jbc.M606615200
Functional dissection identifies a conserved noncoding sequence-1 core that mediates IL13 and IL4 transcriptional enhancement
Abstract
Conserved noncoding sequence (CNS)-1 has been shown to coordinately regulate the expression of the Th2 cytokine genes IL4, IL13, and IL5. We have used the interaction between CNS-1 and the human IL13 and IL4 promoters as a model to pursue the molecular mechanisms underlying CNS-1-dependent regulation of Th2 cytokine gene transcription. CNS-1 potently enhanced the activity of IL13 and IL4 promoter reporter vectors upon full T cell activation. Analysis of CNS-1 deletion mutants mapped enhancer activity to a short core (CNS-1-(270-337)) that contains three closely spaced cyclic AMP-responsive elements (CRE). CRE site 2 bound CRE-binding protein (CREB) and activating transcription factor (ATF)-2 in vitro and was essential for CNS-1-dependent up-regulation of IL13 transcription. Cotransfection of an IL13 reporter construct with expression vectors for wild type or mutant CREB and ATF-2 showed that CREB, but not ATF-2, regulates CNS-1 enhancer activity. Notably, chromatin immunoprecipitation analysis showed T cell activation recruits CREB and the coactivator CREB-binding protein (CBP)/p300 to the endogenous CNS-1. Moreover, CBP/p300 activity was essential for CNS-1-mediated enhancement of IL13 transcription. Collectively, these data define the region within CNS-1 responsible for enhancement of IL13 and IL4 transcription and suggest CREB/CBP-dependent mechanisms play an important role in facilitating Th2 cytokine gene expression in response to T cell receptor signaling.
Similar articles
-
NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells.J Biol Chem. 2010 Mar 12;285(11):8256-67. doi: 10.1074/jbc.M109.041004. Epub 2010 Jan 5. J Biol Chem. 2010. PMID: 20051514 Free PMC article.
-
Characterization of a palindromic enhancer element in the promoters of IL4, IL5, and IL13 cytokine genes.J Allergy Clin Immunol. 2003 Apr;111(4):826-32. doi: 10.1067/mai.2003.1377. J Allergy Clin Immunol. 2003. PMID: 12704365
-
Chromatin landscape dynamics of the Il4-Il13 locus during T helper 1 and 2 development.Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11410-5. doi: 10.1073/pnas.0403334101. Epub 2004 Jul 22. Proc Natl Acad Sci U S A. 2004. PMID: 15272080 Free PMC article.
-
Interleukin 4/13 signaling in cardiac regeneration and repair.Am J Physiol Heart Circ Physiol. 2022 Nov 1;323(5):H833-H844. doi: 10.1152/ajpheart.00310.2022. Epub 2022 Sep 23. Am J Physiol Heart Circ Physiol. 2022. PMID: 36149768 Free PMC article. Review.
-
Neuroprotective modulation of microglia effector functions following priming with interleukin 4 and 13: current limitations in understanding their mode-of-action.Brain Behav Immun. 2020 Aug;88:856-866. doi: 10.1016/j.bbi.2020.03.023. Epub 2020 Mar 26. Brain Behav Immun. 2020. PMID: 32224056 Review.
Cited by
-
Functional involvement of dual specificity phosphatase 16 (DUSP16), a c-Jun N-terminal kinase-specific phosphatase, in the regulation of T helper cell differentiation.J Biol Chem. 2011 Jul 15;286(28):24896-905. doi: 10.1074/jbc.M111.245019. Epub 2011 May 25. J Biol Chem. 2011. PMID: 21613215 Free PMC article.
-
NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells.J Biol Chem. 2010 Mar 12;285(11):8256-67. doi: 10.1074/jbc.M109.041004. Epub 2010 Jan 5. J Biol Chem. 2010. PMID: 20051514 Free PMC article.
-
High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma.J Oncol. 2020 Dec 16;2020:8868245. doi: 10.1155/2020/8868245. eCollection 2020. J Oncol. 2020. PMID: 33381179 Free PMC article.
-
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.Front Immunol. 2019 Jun 6;10:925. doi: 10.3389/fimmu.2019.00925. eCollection 2019. Front Immunol. 2019. PMID: 31244820 Free PMC article. Review.
-
Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target.Oncotarget. 2016 Jun 7;7(23):35454-65. doi: 10.18632/oncotarget.7721. Oncotarget. 2016. PMID: 26934558 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous